Molecule Details
| InChIKey | ZOHCDJRFYXKEQW-UHFFFAOYSA-N |
|---|---|
| Compound Name | 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One |
| Canonical SMILES | O=c1c2c(O)cccc2oc2c([N+](=O)[O-])ccc(O)c12 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.1 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB02170 |
|---|---|
| Drug Name | 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 11314 ChEBI: 77321 CHEMBL270512 ChemSpider: 4484006 PDB: MNX PubChem:5326637 PubChem:46508489 ZINC: ZINC000012501685
Target Activities (4)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P68400 | CSNK2A1 | Casein kinase II subunit alpha | binder | targets |